This article considers neuraminidase inhibitors, which are active against influenza virus and are crucial to planning for an influenza pandemic from a new influenza virus of any origin, including a ...

Cidara Therapeutics, a US biotech leveraging its Cloudbreak platform for next‑generation antivirals, saw its stock more than ...

Development of novel influenza neuraminidase inhibitors is critical for preparedness against influenza outbreaks. Knowledge of the neuraminidase enzymatic mechanism and transition-state analogue ...

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality. Current ...

As 2017 closes out, national influenza activity is increasing. All 10 US regions characterized by the CDC have reported elevated outpatient influenza-like illness, i.e., above the national or ...

This winter, the circulating strain of seasonal influenza A virus (H1N1) is resistant to the neuraminidase inhibitor oseltamivir. Moreover, rather than emerging under selective pressure of drug ...

Please use one of the following formats to cite this article in your essay, paper or report: APA Dutta, Sanchari Sinha Dutta. (2023, February 07). Study characterizes mutations in neuraminidase of ...

Its full scientific name is avian influenza A(H5N1), so it contains hemagglutinin 5 and neuraminidase 1. Bird flu primarily affects birds, as per the name, but has adapted to infect cows and can ...

Conclusions: Oseltamivir administered daily for six weeks by the oral route is safe and effective for the prevention of influenza. Context: The neuraminidase inhibitor zanamivir, a sialic acid ...

The study (“Broadly protective human antibodies that target the active site of influenza virus neuraminidase”) in Science, which Scripps Research conducted jointly with Washington University ...

InDevR's game-changing VaxArray® vaccine potency testing platform now includes a reagent kit for rapid assessment of neuraminidase in influenza vaccines BOULDER COLORADO (6/12/18) -- InDevR Inc ...